U
COV

UBS’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

UBS’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$986K Buy
11,400
+10,900
+2,180% +$965K ﹤0.01% 3605
2014
Q2 		$45K Sell
500
-9,900
-95% -$741K ﹤0.01% 7023
2014
Q1 		$766K Buy
10,400
+10,000
+2,500% +$697K ﹤0.01% 3771
2013
Q4 		$27K Buy
400
+200
+100% +$13K ﹤0.01% 7803
2013
Q3 		$12K Sell
200
-5,327
-96% -$325K ﹤0.01% 8690
2013
Q2 		$308K Buy
+5,527
New +$320K ﹤0.01% 4609

Other funds holding COV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

UBS's COV Position: Q3 2014 in Review

UBS reduced its COVIDIEN PLC COM SHS NEW (IRELAND) (COV) stake by 19% in Q3 2014, selling an estimated $23.4M and leaving 1,103,070 shares worth $95.4M. The position accounts for 0.07% of the portfolio, ranked #285.

UBS first reported a position in COV in Q2 2013 and has held it in 6 quarters since. The position peaked at $123M in Q2 2014. 720 funds tracked by Wall St. Rank hold COV as of Q3 2014.

  • UBS held 1,103,070 shares of COVIDIEN PLC COM SHS NEW (IRELAND) worth $95.4M as of Q3 2014.
  • UBS sold 263,932 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q3 2014, an estimated $23.4M.
  • COVIDIEN PLC COM SHS NEW (IRELAND) made up 0.07% of UBS's portfolio in Q3 2014, its #285 holding.
  • UBS first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and has held it in 6 quarters since.
  • UBS's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $123M in Q2 2014.
  • 720 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.